Sinovac Biotech Gets Positive Decision from WHO on Healive


Adverum Bio Initiates Advance Phase 1/2 Trial of ADVM-043


Odonate Begins Phase 3 Study of Tesetaxel


NeuClone Discloses Details of Denosumab' Biosimilar Candidate


Frutarom Acquires AB-Fortis


Researchers Explore Complex Genetic Network behind Sleep Duration


Glenmark's Phase 3 Safety Study Evaluating Ryaltris in Patients with PAR Meets Primary Endpoint


Daiichi Sankyo, Puma Biotech Sign Research Pact with MSK Cancer Centre


BIRAC Invites Research Proposals in the Areas of Vaccines, Biotherapeutics


Karnataka Woos Scientists and Entrepreneurs


US FDA Accepts Ascentage's IND Application for APG-1387


Bayer, PeptiDream Ink Global Drug Discovery Pact


GVK BIO Completes 10 Year Collaboration with Nuevolution


GNA Biosolutions to Introduce Pharos V8 for In Vitro Research Use


Noxxon Pharma Inks Deal with NCT in Heidelberg


Biogen Buys Remedy Pharma's CIRARA


ix Biopharma Reports Positive Results from Pharmacokinetic Study of Bnox


Seres Therapeutics to Initiate New SER-109 Phase 2 Study


Amarantus to Acquire Certain Biotech Assets from SeD BioMedical


USPTO Grants Patent for Kadimastem Cell Based Treatment


Pharnext Initiates Phase 3 Extension Study PLEO-CMT-FU of PXT3003


Sanofi, Lonza Collaborate to Set up Large-scale Biologics Production Unit


Researchers Find Novel Target for Controlling Immune Response to Implanted Materials